Victor S. Pribluda - Concepedia

Author

Victor S. Pribluda

Also Known As

Pribluda, Victor, V PRIBLUDA, V Pribluda, V S Pribluda, V. S. Pribluda, V.S. Pribluda, Victor PRIBLUDA, Victor Pribluda, Victor S Pribluda, Victor S. Pribluda

Publications

3.4K

Citations

H-Index

Concepts

All Affiliations

CASI Pharmaceuticals (United States)National Institute of Arthritis and Musculoskeletal and Skin Diseases United States Pharmacopeial Convention National Institutes of Health Anton de Kom University of Suriname

About

Victor S. Pribluda is an author at CASI Pharmaceuticals (United States) specializing in medicine, pharmacology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	14	2.1K
2	Natural Sciences	2	2	40
3	Public Health	2	2	124
4	Health Sciences	1	1	197
5	Social Sciences	1	1	18

Victor S. Pribluda

Publications

2.6K

Citations

H-Index

Page 1

	Year	Citations
2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF Nicola J. Mabjeesh, Daniel Escuín, Theresa LaVallee, Cancer Cell Tumor BiologyAngiogenesisMedicineVascular BiologyInhibits Tumor Growth	2003	726
Withaferin A is a potent inhibitor of angiogenesis Royce Mohan, Hans J. Hammers, Paola Bargagna‐Mohan, Angiogenesis InflammationAngiogenesisPotent InhibitorMedicineEndothelial Dysfunction	2004	380
2-Methoxyestradiol inhibits proliferation and induces apoptosis independently of estrogen receptors alpha and beta. Theresa LaVallee, Xiaoguo H. Zhan, Chris J Herbstritt, PubMed Estradiol MetabolitesChemoprevention StrategyGynecologyCell DeathFemale Reproductive Function	2002	205
Tissue factor/factor VIIa inhibitors block angiogenesis and tumor growth through a nonhemostatic mechanism. Todd Hembrough, Glenn M. Swartz, Adonia E. Papathanassiu, PubMed ImmunologyTumor BiologyThrombosisAngiogenesisCoagulation Inhibitors	2003	197
Transphosphorylation as the mechanism by which the high-affinity receptor for IgE is phosphorylated upon aggregation. Victor S. Pribluda, Clara Pribluda, H Metzger Proceedings of the National Academy of Sciences Mast Cell DisorderImmunologyCytoskeletonHigh-affinity ReceptorCellular Physiology	1994	195
2-methoxyestradiol up-regulates death receptor 5 and induces apoptosis through activation of the extrinsic pathway. Theresa LaVallee, Xiaoguo H. Zhan, Michelle S. Johnson, PubMed Chemoprevention StrategyApoptosisGynecologyCell DeathTumor Biology	2003	142
2-Methoxyestradiol Inhibits Hypoxia-Inducible Factor 1α, Tumor Growth, and Angiogenesis and Augments Paclitaxel Efficacy in Head and Neck Squamous Cell Carcinoma Justin L. Ricker, Zhong Chen, Xin Yang, Clinical Cancer Research	2004	126
Monitoring the Quality of Medicines: Results from Africa, Asia, and South America Mustapha Hajjou, Laura Krech, Lukas Roth, American Journal of Tropical Medicine and Hygiene Quality TestPharmacotherapySouth AmericaDrug MonitoringPublic Health	2015	69
Dynamics of membrane-cytoskeleton interactions in activated blood platelets Victor S. Pribluda, Avner Rotman Biochemistry	1982	62
Identification and characterization of a very low density lipoprotein receptor-binding peptide from tissue factor pathway inhibitor that has antitumor and antiangiogenic activity Todd Hembrough, José F. Ruiz, Bonnie Swerdlow, Blood	2004	56

Page 1